[go: up one dir, main page]

NO20031941L - Diagnostisk fremgangsmåte - Google Patents

Diagnostisk fremgangsmåte

Info

Publication number
NO20031941L
NO20031941L NO20031941A NO20031941A NO20031941L NO 20031941 L NO20031941 L NO 20031941L NO 20031941 A NO20031941 A NO 20031941A NO 20031941 A NO20031941 A NO 20031941A NO 20031941 L NO20031941 L NO 20031941L
Authority
NO
Norway
Prior art keywords
diagnostic procedure
animal
sample
megakaryocyte
tse
Prior art date
Application number
NO20031941A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031941D0 (no
Inventor
Michael Clinton
Gino Miele
Jean Catherine Manson
Original Assignee
Roslin Inst Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roslin Inst Edinburgh filed Critical Roslin Inst Edinburgh
Publication of NO20031941D0 publication Critical patent/NO20031941D0/no
Publication of NO20031941L publication Critical patent/NO20031941L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20031941A 2000-10-31 2003-04-29 Diagnostisk fremgangsmåte NO20031941L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026604.9A GB0026604D0 (en) 2000-10-31 2000-10-31 Diagnostic method
PCT/GB2001/004806 WO2002037119A2 (fr) 2000-10-31 2001-10-29 Methode de diagnostic

Publications (2)

Publication Number Publication Date
NO20031941D0 NO20031941D0 (no) 2003-04-29
NO20031941L true NO20031941L (no) 2003-06-27

Family

ID=9902283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031941A NO20031941L (no) 2000-10-31 2003-04-29 Diagnostisk fremgangsmåte

Country Status (16)

Country Link
US (2) US6962787B2 (fr)
EP (1) EP1348128A2 (fr)
JP (1) JP2004513347A (fr)
KR (1) KR20030053522A (fr)
CN (1) CN1473272A (fr)
AU (2) AU2002210740B2 (fr)
BR (1) BR0115090A (fr)
CA (1) CA2427004A1 (fr)
GB (1) GB0026604D0 (fr)
IL (1) IL155614A0 (fr)
MX (1) MXPA03003855A (fr)
NO (1) NO20031941L (fr)
NZ (1) NZ525905A (fr)
RU (1) RU2313790C2 (fr)
WO (1) WO2002037119A2 (fr)
ZA (1) ZA200303066B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1556702A2 (fr) * 2002-10-30 2005-07-27 Proteome Sciences Plc Methodes destinees a diagnostiquer une encephalopathie spongiforme transmissible
DE10261529A1 (de) * 2002-12-23 2004-07-08 Indivumed Gmbh Verfahren zur Erstellung einer Sammlung von biologischem Probenmaterial und Probensammlung
GB0426859D0 (en) * 2004-12-07 2005-01-12 Proteome Sciences Plc Diagnosis of neurodegenerative disorders
WO2011027966A2 (fr) * 2009-09-03 2011-03-10 Seegene, Inc. Sonde td et ses utilisations
WO2013059413A1 (fr) * 2011-10-18 2013-04-25 The Children's Hospital Of Philadelphia Anticorps protéiques de stabilisation de l'alpha-hémoglobine et leurs procédés d'utilisation
RU2475745C1 (ru) * 2012-04-10 2013-02-20 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ прогнозирования желудочно-кишечных заболеваний с синдромом диареи у новорожденных телят
CN105738614B (zh) * 2016-02-23 2017-12-05 山东大学 一种应用流式细胞仪分析评价小鼠骨髓红细胞生成功能的方法
CN113235940B (zh) * 2021-06-09 2024-08-02 中国水利水电第七工程局有限公司 一种一体化便捷式钢筋间距快速标点辅助工具
CN113235930B (zh) * 2021-06-09 2024-08-02 中国水利水电第七工程局有限公司 一种快速钢筋间距标点的辅助工具

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874301A (en) * 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5679530A (en) * 1995-04-12 1997-10-21 Ludwig Institute For Cancer Research Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein
KR100281109B1 (ko) * 1997-12-15 2001-03-02 김영환 에스오아이(soi)소자및그의제조방법
CA2359132A1 (fr) * 1999-01-15 2000-07-20 Roxanne D. Duan Proteine specifique de la moelle osseuse
DE19918141A1 (de) 1999-04-21 2000-10-26 Boehringer Ingelheim Vetmed Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
WO2001019860A2 (fr) 1999-09-15 2001-03-22 Incyte Genomics, Inc. Proteines associees a la differenciation cellulaire

Also Published As

Publication number Publication date
BR0115090A (pt) 2003-10-07
US7413865B2 (en) 2008-08-19
AU1074002A (en) 2002-05-15
AU2002210740B2 (en) 2006-02-23
MXPA03003855A (es) 2004-04-20
US20060051813A1 (en) 2006-03-09
US6962787B2 (en) 2005-11-08
ZA200303066B (en) 2004-07-19
JP2004513347A (ja) 2004-04-30
US20020164661A1 (en) 2002-11-07
WO2002037119A2 (fr) 2002-05-10
EP1348128A2 (fr) 2003-10-01
IL155614A0 (en) 2003-11-23
GB0026604D0 (en) 2000-12-13
CA2427004A1 (fr) 2002-05-10
WO2002037119A3 (fr) 2003-01-16
NZ525905A (en) 2004-08-27
NO20031941D0 (no) 2003-04-29
KR20030053522A (ko) 2003-06-28
CN1473272A (zh) 2004-02-04
RU2313790C2 (ru) 2007-12-27

Similar Documents

Publication Publication Date Title
De Morais et al. Matrix metalloproteinase‐8 levels in periodontal disease patients: A systematic review
Qi et al. Oral health conditions and COVID-19: A systematic review and meta-analysis of the current evidence
NO20031941L (no) Diagnostisk fremgangsmåte
Kim et al. GlycoGrip: cell surface-inspired universal sensor for betacoronaviruses
McMahon et al. Swadesh Sublists and the benefits of borrowing: an Andean case study 1
BR0210881A (pt) Método para gerenciamento de componente de empreendimento, meio legìvel por computador, sistema para a determinação de uma causa de origem de um evento de empreendimento, método de prover e selecionar a partir de um conjunto de entradas de dado no exibidor, conjunto de interfaces de programa de aplicação e sistema para correlacionar eventos e determinar um evento de base
SE9401351D0 (sv) A method for diagnosis
EP1804573A4 (fr) Methodes et appareil permettant d'identifier et de diagnostiquer des oeufs vivants a l'aide de la frequence cardiaque et du mouvement d'un embryon
BR9911263A (pt) Método de recuperação de dados e aparato com capacidade de múltiplas fontes
EP0883271A3 (fr) Procédé et système de gestion des systèmes de service de données
EA200300126A1 (ru) Ранняя диагностика конформационных заболеваний
WO2009096799A3 (fr) Configurations pour réseaux
Schiødt et al. Periodontal disease in primary Sjögren's syndrome
Obashi et al. A conformational switch in clathrin light chain regulates lattice structure and endocytosis at the plasma membrane of mammalian cells
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
CA2379428A1 (fr) Appareil de traite automatique d'animaux
BRPI0509978A (pt) uso de padrão proteÈmico de plasma para diagnóstico, classificação, previsão de resposta à terapia e comportamento clìnico, estratificação de terapia, e monitoramento de doença em malignidades hematológicas
BRPI0516149B8 (pt) instrumento de medição da elasticidade de um órgão do tipo que envolve um meio de centralização
Sinnott‐Armstrong et al. Multiple origins of lipid‐based structural colors contribute to a gradient of fruit colors in Viburnum (Adoxaceae)
Khawaja et al. Potential speech features for cognitive load measurement
Tomczyk et al. Periodontitis in the historical population of Radom (Poland) from the 11th to 19th centuries
AR037141A1 (es) Un metodo para identificar interacciones entre dos farmacos y una disposicion de screening de bibliotecas para determinar la interaccion de un farmaco de ensayo con un miembro de una biblioteca de farmacos en un ensayo
Henrich et al. Rhythmic disturbance in ataxic dysarthria: A comparison of different measures and speech tasks
Reitsema et al. Brief communication: Oxygen isotopes as a biomarker for sickle‐cell disease? Results from transgenic mice expressing human hemoglobin S genes
RU2003116905A (ru) Способ диагностики

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application